KILITCH DRUGS (INDIA) LTD. - 524500 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Kilitch Drugs India Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here KILITCH DRUGS (INDIA) LTD. - 524500 - Shareholding for the Period Ended December 31, 2021
Kilitch Drugs India Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2021. For more details, kindly Click here KILITCH DRUGS (INDIA) LTD. - 524500 - SCRUTINIZER REPORT AND VOTING RESULTS OF THE EXTRA ORDINARY GENERAL MEETING OF THE COMPANY
Dear Sir/ Ma'am, The Company's Extra Ordinary General Meeting (AGM) was held on Wednesday, 19th January 2022 at 01:00 P.M through video conferencing or other audio visual means. In terms of the provisions of the Companies Act, 2013 and the Rules made thereunder and as per the provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company had provided remote E-voting facility to its members. Mr. Deep Shukla, Proprietor of M/s Deep Shukla and Associates, Company Secretaries was appointed as the Scrutinizer to scrutinize the voting conducted through remote e-voting for the EGM. The Scrutinizer's Report dated 19th January 2022, is attached as Annexure I. In terms of the provisions of Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the details of the results held through remote e-voting is attached herewith as Annexure II. Kindly take the above intimation on record. KILITCH DRUGS (INDIA) LTD. - 524500 - Proceedings Of EGM Held On 19-01-2022
PROCEEDINGS OF EXTRA-ORDINARY GENERAL MEETING (EGM) OF THE COMPANY HELD ON WEDNESDAY, JANUARY 19, 2022 THROUGH VC/OAVM. KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended December 2021 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Princy AsatiDesignation :- Company Secretary and Compliance Officer KILITCH DRUGS (INDIA) LTD. - 524500 - Statement Of Investor Complaints For The Quarter Ended December 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Princy AsatiDesignation :- Company Secretary and Compliance Officer KILITCH DRUGS (INDIA) LTD. - 524500 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith certificate issued by the Registrar & Share Transfer Agent M/s. Link Intime India Private Limited confirming the compliance of Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018. KILITCH DRUGS (INDIA) LTD. - 524500 - Closure of Trading Window
This is to inform you that pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time read with NSE Circular Reference no. NSE/CML/2019/11 and BSE Circular Reference no. LIST/COMP/01/2019-20, both dated April 02, 2019 Trading Window for dealing in Securities of the Company will remain closed for all Directors, Officers, Designated Persons of the Company and their immediate relatives with effect from Saturday, January 01, 2022 till 48 hours after the declaration of unaudited Financial Results of the Company for the quarter ended December 31, 2021. The date of meeting of Board of Directors to approve the unaudited Financial Results of the Company for the quarter ended December 31, 2021 will be informed in due course. KILITCH DRUGS (INDIA) LTD. - 524500 - Announcement under Regulation 30 (LODR)-Newspaper Publication
In compliance with Regulation 30 read with Schedule III and Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith a copy of newspaper publications published on December 23, 2021 in following newspapers pertaining to Extra Ordinary General Meeting and dispatch of Notice to the Members in relation thereto. 1.Free Press Journal- English Daily 2.Navshakti- Marathi Daily KILITCH DRUGS (INDIA) LTD. - 524500 - Notice Of Extra Ordinary General Meeting
Extraordinary General Meeting of the Members of KILITCH DRUGS (INDIA) LIMITED will be held on Wednesday, 19th January, 2022 at 01:00 P.M. through Video Conference ('VC')/ Other Audio Visual Means ('OAVM') to transact the following Business: To create, offer, issue and allot Convertible Warrants on Preferential Basis to Promoters of the Company